Literature DB >> 10462517

PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated beta-catenin.

N Ilan1, S Mahooti, D L Rimm, J A Madri.   

Abstract

Catenins function as regulators of cellular signaling events in addition to their previously documented roles in adherens junction formation and function. Evidence to date suggests that beta and gamma catenins can act as signaling molecules, bind transcriptional factors and translocate to the nucleus. Beta- and gamma-catenin are also major substrates for protein tyrosine kinases, and tyrosine phosphorylation of junctional proteins is correlated with decreased adhesiveness. One way in which catenin functions are modulated is by dynamic incorporation into junctional complexes which controls, in part, the cytoplasmic levels of catenins. Here we show that: (1) vascular endothelial growth factor (VEGF) induces beta-catenin tyrosine phosphorylation in a time-, and dose-dependent manner and that VEGF receptors co-localize to areas of endothelial cell-cell contact in vitro and in vivo. (2) Platelet-endothelial cell adhesion molecule (PECAM)-1 can function as a reservoir for, and modulator of, tyrosine phosphorylated beta-catenin. (3) PECAM-1 can prevent beta-catenin nuclear translocation in transfected SW480 colon carcinoma cells. We suggest that PECAM-1 may play a role in modulating beta-catenin tyrosine phosphorylation levels, localization and signaling and by doing so, functions as an important modulator of the endothelium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10462517     DOI: 10.1242/jcs.112.18.3005

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  31 in total

Review 1.  Heart valve development: endothelial cell signaling and differentiation.

Authors:  Ehrin J Armstrong; Joyce Bischoff
Journal:  Circ Res       Date:  2004-09-03       Impact factor: 17.367

Review 2.  Valvulogenesis: the moving target.

Authors:  Jonathan T Butcher; Roger R Markwald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

3.  CD44: target for antiangiogenesis therapy.

Authors:  Horace M DeLisser
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

4.  PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradation.

Authors:  Purba Biswas; Sandra Canosa; David Schoenfeld; Jonathan Schoenfeld; Puyau Li; Lydia C Cheas; Jin Zhang; Alfredo Cordova; Bauer Sumpio; Joseph A Madri
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 5.  Mechanosignaling in the vasculature: emerging concepts in sensing, transduction and physiological responses.

Authors:  Shampa Chatterjee; Keigi Fujiwara; Néstor Gustavo Pérez; Masuko Ushio-Fukai; Aron B Fisher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-10       Impact factor: 4.733

Review 6.  Diabetic retinopathy: Breaking the barrier.

Authors:  Randa S Eshaq; Alaa M Z Aldalati; J Steven Alexander; Norman R Harris
Journal:  Pathophysiology       Date:  2017-07-12

7.  Angiopoietins-1 and -2 play opposing roles in endothelial sprouting of embryoid bodies in 3D culture and their receptor Tie-2 associates with the cell-cell adhesion molecule PECAM1.

Authors:  Angel Gu; John E Shively
Journal:  Exp Cell Res       Date:  2011-06-23       Impact factor: 3.905

8.  RhoA goes GLOBAL.

Authors:  Caitlin Collins; Ellie Tzima
Journal:  Small GTPases       Date:  2013-03-19

9.  Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice.

Authors:  Donnasue Graesser; Anna Solowiej; Monika Bruckner; Emily Osterweil; Amy Juedes; Sandra Davis; Nancy H Ruddle; Britta Engelhardt; Joseph A Madri
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

10.  Role of Ceacam1 in VEGF induced vasculogenesis of murine embryonic stem cell-derived embryoid bodies in 3D culture.

Authors:  Angel Gu; Walter Tsark; Kathryn V Holmes; John E Shively
Journal:  Exp Cell Res       Date:  2009-03-10       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.